Clinical Trial Update: Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study [NA]

View source ↗

Summary

Phase I clinical trial evaluating a mobile medication adherence platform for buprenorphine-naloxone in treating opioid use disorder; study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: Washington State University | Conditions: Opioid-use Disorder | NA | Status: COMPLETED | Results posted: 2023-02-10